Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response. | J Transl Med | 2021 | 33985530 | PubTator, text mining | PubMed |
| The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment. | Cancer Med | 2021 | 33982444 | PubTator, text mining | PubMed |
| Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma. | Signal Transduct Target Ther | 2021 | 33976105 | PubTator, text mining | PubMed |
| Limited inhibition of multiple nodes in a driver network blocks metastasis. | Elife | 2021 | 33973518 | PubTator, text mining | PubMed |
| Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. | Nat Commun | 2021 | 33972544 | PubTator, text mining | PubMed |
| Amplification of DDR2 mediates sorafenib resistance through NF-κB/c-Rel signaling in hepatocellular carcinoma. | Cell Biol Int | 2021 | 33969575 | PubTator, text mining | PubMed |
| Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer. | Front Oncol | 2021 | 33968723 | PubTator, text mining | PubMed |
| Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma. | Front Endocrinol (Lausanne) | 2021 | 33967965 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Effects of Low-Dose Gestational TCDD Exposure on Behavior and on Hippocampal Neuron Morphology and Gene Expression in Mice. | Environ Health Perspect | 2021 | 33956508 | PubTator, text mining | PubMed |
| Identification of a novel homozygous mutation in the DDR2 gene from a patient with spondylo-meta-epiphyseal dysplasia by whole exome sequencing. | Iran J Basic Med Sci | 2021 | 33953858 | PubTator, text mining | PubMed |
| Proteolytic Cleavage of Receptor Tyrosine Kinases. | Biomolecules | 2021 | 33947097 | PubTator, text mining | PubMed |
| The Dynamic Interaction between Extracellular Matrix Remodeling and Breast Tumor Progression. | Cells | 2021 | 33946660 | PubTator, text mining | PubMed |
| Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations. | Genes (Basel) | 2021 | 33946594 | PubTator, text mining | PubMed |
| Selective multiplexed enrichment for the detection and quantitation of low-fraction DNA variants via low-depth sequencing. | Nat Biomed Eng | 2021 | 33941896 | PubTator, text mining | PubMed |
| EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 33923116 | PubTator, text mining | PubMed |
| Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact. | Cancers (Basel) | 2021 | 33923068 | PubTator, text mining | PubMed |
| Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 33922215 | PubTator, text mining | PubMed |
| Concomitant Mutations G12D and G13D on the Exon 2 of the KRAS Gene: Two Cases of Women with Colon Adenocarcinoma. | Diagnostics (Basel) | 2021 | 33917572 | PubTator, text mining | PubMed |
| The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development. | Cancers (Basel) | 2021 | 33917302 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=48